Clinical Trial Update: Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administration [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial investigating prolonged administration of endothelin receptor antagonists for pulmonary hypertension has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Snippet

Sponsor: Center for Health Sciences, Serbia | Conditions: Pulmonary Hypertension | Phase 2, Phase 3 | Status: COMPLETED